• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human Phospho-SMAD1-S463/S465+SMAD5-S463/S465+SMAD9-S465/S467 Monoclonal Antibody

The antibody against Phospho-SMAD1-S463/S465+SMAD5-S463/S465+SMAD9-S465/S467 was raised in Rabbit using a synthetic phosphorylated peptide around S463/S465//S467 of human SMAD1/SMAD5/SMAD9 as the immunogen. The monoclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IHC-P, ELISA.

ADA-15613A

The antibody against Phospho-SMAD1-S463/S465+SMAD5-S463/S465+SMAD9-S465/S467 was raised in Rabbit using a synthetic phosphorylated peptide around S463/S465//S467 of human SMAD1/SMAD5/SMAD9 as the immunogen. The monoclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IHC-P, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-15613A ClonalityMonoclonal
Host SpeciesRabbitTarget NamePhospho-SMAD1-S463/S465+SMAD5-S463/S465+SMAD9-S465/S467
Target SynonymsBSP1; MADH1; MADR1; JV4-1; DWFC; JV5-1; MADH5; MADH6; MADH9; SMAD8; Phospho-SMAD1-S463/S465+SMAD5-S463/S465+SMAD9-S465/S467FormLiquid
Species ReactivityHuman, Mouse, RatIsotypeIgG
Storage Buffer50% Glycerol, 0.05% BSA, PBS with 0.05% proclin300, pH7.3.Purification MethodAffinity purification
Positive SamplesC6 cells were treated by TGF beta 3 and MG132ApplicationELISA, WB, IHC-P

Immunogen Information


Immunogen DescriptionA synthetic phosphorylated peptide around S463/S465//S467 of human SMAD1/SMAD5/SMAD9.Target SpeciesHuman
Immunogen SequencePISSVSUniprot IDQ15797, Q99717, O15198

Inquire Rabbit anti-Human Phospho-SMAD1-S463/S465+SMAD5-S463/S465+SMAD9-S465/S467 Monoclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification